MiniMed (MMED) launched its Flex insulin pump system in the US, the company said Wednesday.
The system is cleared by the US Food and Drug Administration for people aged 7 and older with type 1 diabetes and adults with insulin-requiring type 2 diabetes, MiniMed said.
The Flex system is the company's first app-controlled insulin pump and is paired at launch with the Simplera Sync, a disposable continuous glucose monitoring sensor, the company said.
Price: $15.14, Change: $+0.44, Percent Change: +2.99%